Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether hepatitis B immunoglobin can be
discontinued early after hepatitis B virus (HBV) induced liver transplantation and be
replaced by the nucleoside analogue entecavir to prevent hepatitis B reinfection.